Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1986 1
1989 3
1990 7
1991 5
1992 1
1993 9
1994 14
1995 5
1996 4
1997 3
1998 7
1999 2
2000 5
2001 1
2002 4
2003 6
2004 5
2005 8
2006 5
2007 12
2008 11
2009 7
2010 4
2011 12
2012 8
2013 6
2014 8
2015 5
2016 4
2017 1
2018 3
2019 7
2020 7
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

178 results

Results by year

Filters applied: . Clear all
The following term was ignored: or
Page 1
Imaging Characterization of Thyroid Nodules.
Divgi CR. Divgi CR. Acad Radiol. 2019 Feb;26(2):161-162. doi: 10.1016/j.acra.2018.11.007. Epub 2018 Dec 6. Acad Radiol. 2019. PMID: 30528751 No abstract available.
125I-Labeled mouse anti-human carbonic anhydrase IX monoclonal antibody.
Shan L. Shan L. 2012 May 3 [updated 2012 May 30]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2012 May 3 [updated 2012 May 30]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 22675743 Free Books & Documents. Review.
The radionuclide-labeled chimeric antibody cG250 and its Fab and F(ab')2 fragments have been tested by Divgi et al. as molecular probes for imaging clear-cell renal carcinomas and HT29 human colorectal tumor xenografts (10). ...
The radionuclide-labeled chimeric antibody cG250 and its Fab and F(ab')2 fragments have been tested by Divgi et al. as molecular prob …
Do We Need Yet Another Hybrid Imaging Device?
Divgi C. Divgi C. Acad Radiol. 2016 Feb;23(2):131. doi: 10.1016/j.acra.2015.12.002. Epub 2015 Dec 21. Acad Radiol. 2016. PMID: 26719162 No abstract available.
Imaging the multiple facets of immuno-oncology.
Divgi C. Divgi C. Eur J Nucl Med Mol Imaging. 2018 Jan;45(1):121-122. doi: 10.1007/s00259-017-3869-z. Eur J Nucl Med Mol Imaging. 2018. PMID: 29119236 No abstract available.
Molecular imaging of renal cell carcinoma.
Perini R, Pryma D, Divgi C. Perini R, et al. Urol Clin North Am. 2008 Nov;35(4):605-11; vi. doi: 10.1016/j.ucl.2008.07.015. Urol Clin North Am. 2008. PMID: 18992614 Review.
The Current State of Radiopharmaceutical Therapy.
Divgi C. Divgi C. J Nucl Med. 2018 Nov;59(11):1706-1707. doi: 10.2967/jnumed.118.214122. Epub 2018 Jun 29. J Nucl Med. 2018. PMID: 29959211 Free article. No abstract available.
Overcoming Barriers to Radiopharmaceutical Therapy (RPT): An Overview From the NRG-NCI Working Group on Dosimetry of Radiopharmaceutical Therapy.
Divgi C, Carrasquillo JA, Meredith R, Seo Y, Frey EC, Bolch WE, Zimmerman BE, Akabani G, Jacobson DA, Brown B, Davern SM, Hobbs RF, Humm J, Moros EG, Morse D, Papineni R, Zanzonico P, Benedict SH, Sgouros G. Divgi C, et al. Int J Radiat Oncol Biol Phys. 2021 Mar 15;109(4):905-912. doi: 10.1016/j.ijrobp.2020.12.002. Epub 2020 Dec 10. Int J Radiat Oncol Biol Phys. 2021. PMID: 33309909 Free PMC article. Review.
178 results